Oishi Koseido ‘s humble beginnings can be traced back from manufacturing the rubbing ointment Asahi Mankinko
|1907||Oishi Koseido started business as a private company.
Manufactured the Asahi Mankinko rubbing ointment
|1950||Oishi Koseido Co., Ltd. was established in March 1950.
|1957||Manufacturing of PASMAN plasters started at the head office factory.|
|1964||Started manufacturing PASMAN (skin-colored, perforated plasters) at the head office factory.
|1969||Construction of Yamaura Plant was completed and Plaster Division was relocated from the Main Plant.|
|1973||Started manufacturing of Gel Patches for ethical use at the Main Plant.|
|1977||Set up the research and development department at the head office factory.|
|1982||Started manufacturing film plasters at the Yamaura factory.|
|1987||Started manufacturing gel patches for ethical use at the head office factory.|
Oishi Koseido entered a new stage as Showa gave way to Heisei era.
|1990||The Osaka office was established. Ichitaro Oishi was appointed as chairman and Koji Oishi as president.|
|1991||The new Head Office was built.|
|1992||Launched transdermal gel patch INDOMETHACIN PAP for ethical use.|
|1993||Head office plant reconstruction.|
|1994||onstruction of new research laboratory.|
|1996||Construction of new manufacturing building at Yamaura (currently Building No. 2)|
|1997||Tokyo office was established.|
|2001||Market launch of two ethical products: FELBINAC PAP, KETOPROFEN Tape
|2004||Awarded the Saga Prefecture Business Grand Prize.
September: Introduced the defined contribution pension plan (Corporate Independent 401K).
|2007||One Hundredth Anniversary
Completed construction of new factory at Yamaura (Building No. 1).
Merged the manufacturing department at the head office (for Gel Patches) with the Yamaura factory.
|2009||Obtainsed ISO14001 certification. (Yamaura factory)|
|2012||Completes construction of Yamaura factory for manufacturing tape (No. 3 factory).
Market launch of percutaneous absorption bronchodilator for medical use (TULOBUTEROL Tape)
|2013||Market launch of ethical pharmaceutical product LOXOPROFEN SODIUM PAP|
|2014||Koji Oishi was appointed as chairman and Ryoji Nonaka as president.
|2018||Obtained US Food and Drug Administration manufacturing approval
Built Building No. 4 for manufacturing tapes.
Started export of prescription drug ZTlido™ 1.8% to United States of America